Analytica (ALT) Stock Price, News & Analysis

Company Overview

Analytica Limited designs, develops, and supplies medical devices in Australia, China, and the Middle East. The company's lead product includes PeriCoach system, an e-health treatment system for women used in treatment of stress urinary incontinence. Its PeriCoach comprises a device, Web portal, and smartphone app for evaluating activity in pelvic floor muscles. The company also provides Autostart Burette Infusion System for monitoring and refilling of burettes in intravenous fluid infusion. Analytica Limited was incorporated in 1985 and is based in Brisbane, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 37,562 shs
• Average Volume: N/A
• Market Capitalization: $4.61 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: Pharmaceutical Products
• Current Symbol: ASX:ALT
• CIK: N/A
• Web: www.analyticamedical.com
• Phone: 61 7 3278 1950
• Fax: N/A
• Employees: 50
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-2,170,000.00
• Net Margins: -11,595.70%
• Pretax Margin: N/A
• Return on Equity: -230.84%
• Return on Assets: -132.35%

Debt

• Debt-to-Equity Ratio: -307.17
• Current Ratio: 0.35
• Quick Ratio: 0.05

Sales & Book Value

• Annual Sales: $285,386.00
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 4.00
• Book Value: A$0.00 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 4,610,000,000
• Free Float: N/A
• Market Cap: $4.61 million
• Optionable: Not Optionable
• Beta: 1.15